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ABSTRACT
Objective It is well recognised that variation in the
geographical distribution of multiple sclerosis (MS)
exists. Early studies in England have shown the disease
to have been more common in the North than the South.
However, this could be an artefact of inaccurate
diagnosis and ascertainment, and recent data on MS
prevalence are lacking. In the present study, data were
analysed to provide a more contemporary map of the
distribution of MS in England and, as infectious
mononucleosis (IM) has been shown to be associated
with the risk of MS, the geographical distribution of IM
with that of MS was compared.
Methods Analysis of linked statistical abstracts of
hospital data for England between 1999 and 2005.
Results There were 56 681 MS patients. The admission
rate for MS was higher in females (22/105; 95% CI 21.8
to 22.3) than males (10.4/105; 95% CI 10.2 to 10.5). The
highest admission rate for MS was seen for residents of
Cumbria and Lancashire (North of England) (20.1/105;
95% CI 19.3 to 20.8) and the lowest admission rate was
for North West London residents (South of England)
(12.4/105; 95% CI 11.8 to 13.1). The geographical
distributions of IM and MS were significantly correlated
(weighted regression coefficient (r (w))¼0.70,
p<0.0001). Admission rates for MS were lowest in the
area quintile with the highest level of deprivation and
they were also lowest in the area quintile with the
highest percentage of population born outside the UK. A
significant association between northernliness and MS
remained after adjustment for deprivation and UK
birthplace.
Conclusions The results show the continued existence
of a latitude gradient for MS in England and show
a correlation with the distribution of IM. The data have
implications for healthcare provision, because lifetime
costs of MS exceed £1 million per case in the UK, as
well as for studies of disease causality and prevention.
INTRODUCTION
Multiple sclerosis (MS) is the most common disease
of the central nervous system to cause permanent
disability in young adults of Northern European
descent.1 On the basis of strong circumstantial
evidence, MS is thought to be an organ speciﬁc
autoimmune disorder but much remains to be
understood about the initiation of the disease.1 MS
seems unlikely to result from a single causative
event; instead, the disease seems to develop in
genetically susceptible populations as a result of
environmental exposures.2
The most striking illustration of the importance
of the environment in MS is its geographical
distribution.3 MS prevalence is high in Western
Europe and North America, lower in Central and
Eastern Europe, Australia and New Zealand, and
lowest in Asia, the Middle East and Africa.4 Within
regions of temperate climate, MS incidence and
prevalence are thought to increase with latitude.3
The clearest example of this effect is seen in
Australia. The prevalence of MS in Hobart (South
Australia) is 75.6 per 100 000 compared with
a prevalence of 11 per 100 000 in Northern
Queensland.5 The distribution of MS across
England has not been investigated since the mid-
1980s.6 Using all available data at that time,
a gradient in prevalence was observed between
Southern and Northern England.6 7 However, it is
not clear how reliable this map of MS prevalence is
as methodological concerns have been raised,
including differences in diagnostic criteria, meaning
that different studies may not be directly compa-
rable.8 Given that temporal changes in MS preva-
lence have occurred,4 it would be useful to have
a current map of MS across England. This may aid
in understanding the aetiology of the disease but
equally importantly in facilitating the allocation of
healthcare resources given that lifetime costs of MS
exceed £1 million per patient in the UK.9
As the risk of MS is increased in individuals with
a clinical history of infectious mononucleosis (IM)
as a result of EpsteineBarr virus (EBV)
infection,10e12 we also compared the geography of
MS with the distribution of IM.
In this study, we use data from an English
national linked Hospital Episode Statistics (HES)
database to answer three questions: (1) what is the
distribution of admission for MS across England
(using the geography of the NHS Strategic Health
Authorities); (2) is the distribution of admissions for
MS mediated by variations in admission thresholds
across England; and (3) is the geography of admis-
sion for MS correlated with that for IM in England?
METHODS
We analysed data on hospital admissions for MS
using a ﬁle of linked hospital admission statistics,
built from the English national HES system by staff
of the Oxford University Unit of Health-Care
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Epidemiology, covering all admissions to NHS hospitals in
England in the 7 years from 1 April 1998 to 31 March 2005
(population 51 million). The English NHS Central Ofﬁce for
Research Ethics approved the study. We identiﬁed cases of MS as
code G35 in the 10th revision of the International Classiﬁcation
of Diseases. The English national linked HES database includes
information about all people who are admitted to hospital
(including day care as well as overnight stays). Using data
linkage, we identiﬁed each person only once for MS, regardless of
how many admissions each person had, and recorded their
residence at ﬁrst known admission for MS.
We show data mainly for the areas of the 28 English strategic
health authorities (as they were at the time covered by the data).
We also analysed the data at the level of the 352 local authority
(LA) areas and the nine government ofﬁce regions. Admission
rates were calculated using numbers of admissions for residents
of each area as the numerators and the total resident populations
of the area as the denominators. To adjust for differences in the
age structure of different areas, age standardisation was under-
taken using the indirect method and the age speciﬁc rates in 5
year age groups in the English population as the standard. All
rates are expressed per 100 000 population with 95% lower and
upper conﬁdence limits. Rates were calculated separately for
males and females as well as for both sexes combined.
We undertook the same calculations for hospital admissions
for people with IM, motor neuron disease (MND), Hodgkin’s
lymphoma (HL) and non-Hodgkin’s lymphoma (NHL) using the
International Classiﬁcation of Diseases codes B27, G12.2, C81
and C82-85, respectively, to identify them. We analysed the
relationship between the length of hospital stays using a Pearson
correlation and performed a linear weighted regression to
compare the admissions for IM and MS using MATLAB R2009a.
The admission rates by LA were analysed further by grouping
them into government ofﬁce regions as those in Northern
regions (the North East, North West, Yorkshire and the Humber
regions), Midlands (East Midlands and West Midlands), the East
of England region, South East (South East and London regions)
and South West. The LAs were ranked according to the Index of
Multiple Deprivation and grouped into quintiles of deprivation.
The LAs were also ranked according to the percentage of the
population ‘born outside the UK’. People in England who were
born outside the UK are predominantly non-White. We ﬁtted
a model to test the effect of quintile of deprivation and quintile
of people born outside the UK on admission rated by region.
RESULTS
Hospital admission for MS
Table 1 shows the admission rate for MS for both sexes per
100 000 resident population for each strategic health authority
area. There were 56 681 people (39 006 females and 17 562 males)
admitted for MS to hospitals in England in the study period.
This produced a national admission rate of 16.4 admissions per
100 000 (95% CI¼16.2 to 16.5). This rate was higher in females
(22 per 100 000; 95% CI 21.8 to 22.3) than males (10.4 per
100 000; 95% CI 10.2 to 10.5).
Geography of hospital admission for MS
The highest admission rate for MS was seen from residents of
Cumbria and Lancashire (20.1 per 100 000; 95% CI 19.3 to 20.8)
and the lowest admission rate was from North West London
residents (12.39 per 100 000; 95% CI 11.77 to 13.05).
Geographical distributions were similar for males and females
(see supplementary table 1 available online), with North West
London residents having the lowest admission rate for both
males and females, Cumbria and Lancashire residents having the
highest admission rate for females and residents of North-
umberland and Tyne and Wear having the highest admission rate
for males.
Figure 1 shows the data from table 1 and supplementary table
1 in map form. The data are shown as quintiles of geographical
areas with the one-ﬁfth of areas with the lowest rates shown in
the lightest colour and the one-ﬁfth of areas with the highest
rates shown in the darkest colour.
Length of hospital stay for MS
In order to assess whether there is any inﬂuence of the length of
hospital admission on the geography of admission rates for MS,
we compared the geographical distribution of MS for all people
with an admission, all with at least one admission including an
overnight stay (ie, excluding all day case care), all with at least
one stay of 2 days or more and all staying 3 days or more. Our
reasoning was that, if geographical differences in admission rates
for MS result from differences in clinical admission practice,
rather than differences in MS prevalence, the geography of short
stay admissions (which may include admissions that are
discretionary) might differ from that of longer stay admissions
(which probably reﬂects clinical illness that would warrant
admission anywhere). Admission rates in each of these different
‘length of stay’ categories signiﬁcantly correlated with each
other (minimum Pearson correlation¼0.81 (when comparing
stays of 3 days or more with all admissions, p¼23107);
maximum Pearson¼0.99 (when comparing stays of 1 day or
more with stays of 2 days or more, p<131030)) (ﬁgure 2).
Number of admissions per person for MS
In order to further see if our results are related to thresholds for
admission, we took advantage of linked records to identify the
number of admissions per patient in each geographical area. The
England average was 1.96 spells per patient for MS (range
1.59e3.18). There was no correlation between number of
admissions per patient and the standardised person based
admission rate per 100 000 population in the LAs (weighted
regression coefﬁcient (r(w))¼0.06, p¼0.73).
Hospital admission for IM
Table 2 shows the admission rate for IM for both sexes per
100 000 resident population for each strategic health authority
area. There were 14 621 people (6450 females and 8156 males)
admitted for IM to hospitals in England in the study period.
This produced a national admission rate of 4.2 admissions per
100 000 (95% CI 4.2 to 4.3). This rate was higher in males (4.8
per 100 000; 95% CI 4.7 to 4.9) than females (3.6 per 100 000;
95% CI 3.6 to 3.7).
Geography of hospital admission for IM
The highest admission rate for IM was seen from residents of
South Yorkshire (6.60 per 100 000; 95% CI 6.08 to 7.15) and the
lowest admission rate was in North West London residents (2.31
per 100 000; 95% CI 2.06 to 2.59). Geographical proﬁles were
similar for males and females (see supplementary table 2 avail-
able online), with North West London residents having the
lowest admission rates and residents of South Yorkshire having
the highest admission rates for both males and females.
Geographical distributions of hospital admission rates for IM
and MS were analysed for any potential correlations (ﬁgure 3).
Using data for both sexes combined, IM and MS were signiﬁ-
cantly correlated (r(w)¼0.70, p<0.0001). The correlation was
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similar when studying just females (r(w)¼0.69, p<0.0001) and
slightly weaker when studying just males (r(w)¼0.63,
p¼0.0003). This correlation was weaker when looking at the
data when divided into the 352 LAs (r(w) both sexes¼0.47,
p<0.0001) and stronger (but less signiﬁcant) when divided into
the nine government ofﬁce regions (r(w)¼0.84, p¼0.004) (see
supplementary tables 3 and 4 available online).
As a control, we also investigated the geographical distribu-
tions of hospital admissions for MND, HL and NHL for corre-
lations with the geographical distributions of MS and IM. Using
data for both sexes combined, the correlation for MS with MND
was signiﬁcant (r(w)¼0.41, p¼0.03) but not signiﬁcant with
HL or NHL (r(w)¼0.26, p¼0.18; r(w)¼0.2, p¼0.3, respec-
tively). The correlation for IM with MND was non-signiﬁcant
Table 1 Admission rate for multiple sclerosis per 100 000 residents in the strategic health authorities of
England
Strategic health authority Obs Exp
Indirect rate
per 100 000 95% CI
Rank All England 56 681 56 681 16.4 16.2 to 16.5
1 Cumbria and Lancashire 2743 2239.5 20.1 19.3 to 20.8
2 North and East Yorkshire and Northern Lincolnshire 2304 1929.5 19.6 18.8 to 20.4
3 Northumberland, Tyne and Wear 1926 1635.2 19.3 18.4 to 20.2
4 Trent 3578 3100.0 18.9 18.3 to 19.5
5 Norfolk, Suffolk and Cambridgeshire 2961 2582.5 18.8 18.1 to 19.5
6 Dorset and Somerset 1594 1443.4 18.1 17.2 to 19.0
7 Greater Manchester 3053 2817.8 17.7 17.1 to 18.4
8 Avon, Gloucestershire and Wiltshire 2724 2517.3 17.7 17.1 to 18.4
9 Bedfordshire and Hertfordshire 1925 1823.1 17.3 16.5 to 18.1
10 South West Peninsula 2026 1919.6 17.3 16.5 to 18.1
11 South Yorkshire 1534 1458.2 17.2 16.4 to 18.1
12 Kent and Medway 1893 1838.9 16.9 16.1 to 17.6
13 Shropshire and Staffordshire 1799 1763.3 16.7 15.9 to 17.5
14 Surrey and Sussex 3090 3034.5 16.7 16.1 to 17.3
15 County Durham and Tees Valley 1349 1335.8 16.5 15.7 to 17.4
16 Essex 1879 1893.4 16.2 15.5 to 17.0
17 Coventry, Warwickshire, Herefordshire 1727 1802.9 15.7 15.0 to 16.4
18 Cheshire and Merseyside 2583 2737.5 15.5 14.9 to 16.1
19 West Yorkshire 2173 2316.9 15.4 14.7 to 16.0
20 South East London 1431 1614.1 14.5 13.8 to 15.3
21 Hampshire and Isle of Wight 1812 2060.9 14.4 13.7 to 15.1
22 Leicestershire, Northamptonshire and Rutland 1539 1781.0 14.1 13.5 to 14.9
23 Birmingham and the Black Country 2136 2490.4 14.0 13.5 to 14.7
24 Thames Valley 1988 2372.6 13.7 13.1 to 14.3
25 North Central London 1058 1273.6 13.6 12.8 to 14.4
26 North East London 1280 1550.5 13.5 12.8 to 14.3
27 South West London 1118 1422.4 12.9 12.1 to 13.6
28 North West London 1458 1926.2 12.4 11.8 to 13.0
Data in rank order of admission rates.
Obs, observed number of people; Exp, expected number.
Figure 1 Geographical distribution of hospital admission for multiple sclerosis (MS) for (A) females, (B) males and (C) both sexes, showing strategic
health authorities.
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(r(w)¼0.23, p¼0.25), signiﬁcant with HL (r(w)¼0.38,
p¼0.048) and non-signiﬁcant with NHL (r(w)¼0.05, p¼0.8).
Geography of hospital admissions for MS adjusting for
deprivation and ethnicity
When looking at the ﬁve broad areas of England, the highest
admission rate was in the North, at 23% higher than the
national average, and the lowest was the South East (table 3).
There was no consistent trend with deprivation: the lowest
rates for MS in the ﬁve quintiles were in the ﬁrst (least deprived)
quintile and the ﬁfth (most deprived) quintile. Considering place
of birth, as a proxy for ethnicity, the lowest admission rate for
MS was in the quintile with the highest percentage of the
population born outside the UK. The North of England
remained the region with the highest rate after adjustment for
deprivation and (presumed) ethnicity (table 3). After adjustment
of each factor for the other two, the four upper quintiles of
deprivation had signiﬁcantly higher levels of risk than the lowest
quintile (ie, high deprivation was associated with low risk of
MS). Adjustment also conﬁrmed that the quintile with the
highest percentage of the population born outside the UK had
the lowest risk of MS.
DISCUSSION
We present here the most up to date available map of the
distribution of MS in England, using data from a single source.
This method contrasts with previous work on the distribution
of MS in England that used a compilation of data from different
published studies and differing methods of case ascertainment.6
In general, our data indicate a gradient in the frequency of the
disease between Southern and Northern England. This distri-
bution is not related to lengths of hospital stay or number of
admissions per patient, markers for disease severity and
threshold for admission. The distribution of MS across England
is also signiﬁcantly correlated with the distribution of IM,
especially in females. This correlation is not a general phenom-
enon as no signiﬁcant correlation was seen with HL, NHL and
Figure 2 Distribution of hospital admission rates by region according
to length of hospital stay. Rank number refers to rank number of
strategic health authority in table 1.
Table 2 Admission rate for infectious mononucleosis per 100 000 residents in the strategic health
authorities of England
Strategic health authority Obs Exp
Indirect rate
per 100 000 95% CI
All England 14 621 14 621 4.2 4.2 to 4.3
South Yorkshire 595 380.7 6.6 6.1 to 7.2
South West Peninsula 612 433.3 6.0 5.5 to 6.5
Kent and Medway 628 459.6 5.8 5.3 to 6.2
Trent 1031 761.5 5.7 5.4 to 6.1
Dorset and Somerset 402 321.2 5.3 4.8 to 5.8
Norfolk, Suffolk and Cambridgeshire 768 617.0 5.3 4.9 to 5.6
Essex 564 454.5 5.2 4.8 to 5.7
North and East Yorkshire and Northern Lincolnshire 564 470.6 5.1 4.7 to 5.5
County Durham and Tees Valley 404 346.6 4.9 4.5 to 5.4
Northumberland, Tyne and Wear 480 418.0 4.9 4.4 to 5.3
Hampshire and Isle of Wight 566 527.4 4.5 4.2 to 4.9
Surrey and Sussex 712 693.1 4.3 4.0 to 4.7
Shropshire and Staffordshire 442 433.7 4.3 3.9 to 4.7
Avon, Gloucestershire and Wiltshire 623 628.8 4.2 3.9 to 4.5
Cheshire and Merseyside 680 704.3 4.1 3.8 to 4.4
Cumbria and Lancashire 530 556.6 4.0 3.7 to 4.4
Bedfordshire and Hertfordshire 438 468.0 4.0 3.6 to 4.3
Greater Manchester 731 782.8 3.9 3.7 to 4.2
Leicestershire, Northamptonshire and Rutland 441 477.6 3.9 3.5 to 4.3
Coventry, Warwickshire, Herefordshire 408 442.2 3.9 3.5 to 4.3
West Yorkshire 535 654.5 3.5 3.2 to 3.8
Birmingham and the Black Country 581 715.8 3.4 3.2 to 3.7
Thames Valley 477 640.2 3.1 2.9 to 3.4
South West London 260 376.9 2.9 2.6 to 3.3
North Central London 249 369.8 2.8 2.5 to 3.2
South East London 294 452.0 2.7 2.4 to 3.1
North East London 310 493.2 2.7 2.4 to 3.0
North West London 296 541.0 2.3 2.1 to 2.6
Data in rank order of admission rates.
Obs, observed number of people; Exp, expected number.
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a much weaker correlation was observed with MND. Early
studies have suggested that MS is a disease primarily affecting
those in a higher socioeconomic status,13 and therefore
geographical ﬁndings could be confounded by socioeconomic
status. However, taking account of deprivation indices had little
effect on our results, highlighting that socioeconomic factors do
not appear to be a major inﬂuence on hospital admissions for
MS.
The extent of geographical variation is fairly modest: at about
20% between highest and lowest region, it is considerably less
than that found for coronary heart disease, for example.
It is likely that some genetic differences exist between
Northern and Southern English populations but this does not
appear to be the main explanation behind regional differences in
MS period prevalence.6 The similarities between the epidemi-
ology of MS and IM were noted more than two decades ago14
and we show for the ﬁrst time that a correlation exists for the
distribution of MS and IM in England. This correlation is
stronger for females and indeed there is evidence to suggest that
a history of IM may confer differential risk for MS depending on
gender.15 Thus both genes and EBV are implicated in the geog-
raphy of MS but sunlight exposure and associated vitamin D
status are also likely to be a major inﬂuence for the association
between latitude and MS period prevalence in England.2 Inter-
estingly, HL was not associated with MS admissions, high-
lighting potential differences of EBV effects in IM and HL, and
subsequent inﬂuences on MS risk.
MS imposes a signiﬁcant burden on healthcare costs, work
related productive capacity, quality of life and life expectancy of
those affected. An accurate understanding of epidemiological
characteristics of MS may not only provide insights into possible
disease causes and pathogenesis, but also have implications in
healthcare strategies, public health recommendations and focus
of research efforts. At present there are no effective vaccines or
treatments targeting EBV, leaving vitamin D supplementation as
the only available intervention that might result in a reduction
in the prevalence of this often devastating disease.16
There are limitations to our data. Many factors can inﬂuence
MS admission rates. Although we have attempted to control for
this by studying length of stay and number of admissions per
patient, clinical practice preferences may still exist in the
threshold for admission, deﬁnition of relapses and type of
treatment. There may also be differences in the availability of
resources, including numbers of specialist MS staff which can
affect inpatient versus outpatient management. Furthermore,
our data may imply more severe, rather than more prevalent,
MS in the North of England, hence more hospitalisations.
Limitations of record linkage studies using routinely collected
administrative data are well known, and include the facts that
the data are limited to hospitalised patients and that informa-
tion about some variables of potential interest are generally
unavailable. We did not have data at the level of individual
people on ethnicity or socioeconomic status but did our best to
control for this by analysing the aggregate level data for LAs.
Accounting for the proportion of people born outside of the UK
will exclude individuals with generally the lowest risk of MS, as
Figure 3 Scatter plots for admissions per 100 000 for infectious
mononucleosis (IM) and multiple sclerosis (MS) in (A) both sexes, (B)
females and (C) males.
Table 3 Relative risk for multiple sclerosis admission in each area,
deprivation quintile and place of birth quintile, and relative risk for each
factor after adjusting for the other two
Area
Unadjusted
RR
Adjusted
RR
Lower
95% CI
Upper
95% CI
North 1.23 1.19 1.11 1.28
Midlands 1.11 1.05 0.99 1.12
East 1.17 1.12 1.05 1.19
South East/London 1.00 1.00
South West 1.20 1.12 1.04 1.20
Index of Multiple Deprivation quintiles
1 (least deprived) 1.01 1.08 1.01 1.16
2 1.10 1.12 1.05 1.19
3 1.10 1.12 1.05 1.19
4 1.07 1.07 1.01 1.14
5 (most deprived) 1.00 1.00
Percentage born outside UKdquintile
1 (lowest % born out of the UK) 1.24 1.12 1.04 1.20
2 1.24 1.12 1.04 1.20
3 1.18 1.09 1.02 1.16
4 1.16 1.10 1.03 1.16
5 (highest % born out of the UK) 1.00 1.00
CIs for the adjusted relative risk (RR).
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the incidence of MS in second generation migrant populations in
the UK is on the rise.17 Deprivation scores reﬂect the socioeco-
nomic status of the local community and may not wholly reli-
ably reﬂect the status of individuals in our study within each
community. We only analysed hospitalisation for IM and thus
we would underestimate milder cases of IM. However, it may
also be that more severe cases of IM increase the risk of MS to
a greater extent than milder cases.
In conclusion, the distribution of MS across England shows
signiﬁcant although modest variation, at least as measured by
hospitalisation rates. The higher rates in the North than the
South of England persist; they are consistent with earlier ﬁnd-
ings from studies in different parts of the UK and they are
consistent with the more general ﬁnding across the world that
MS prevalence increases with increasing distance from the
equator in both hemispheres. The distribution in England is not
a result of any simple known causative association. Some of the
factors that may be implicated are increasingly recog-
niseddexposure to solar radiation and perhaps late infection
with EBVdand no doubt there are other unknown factors
affecting geographical proﬁles of hospitalisation. The reasons for
the high period prevalence in the North of England need to be
uncovered.
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